These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25799364

  • 1. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
    Giles SL, deSouza NM, Collins DJ, Morgan VA, West S, Davies FE, Morgan GJ, Messiou C.
    Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
    [Abstract] [Full Text] [Related]

  • 2. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C.
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [Abstract] [Full Text] [Related]

  • 3. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
    ElGendy K, Barwick TD, Auner HW, Chaidos A, Wallitt K, Sergot A, Rockall A.
    Br J Radiol; 2022 Sep 01; 95(1138):20220418. PubMed ID: 35867890
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma.
    Chen J, Li C, Tian Y, Xiao Q, Deng M, Hu H, Wen B, He Y.
    AJR Am J Roentgenol; 2019 Sep 01; 213(3):514-523. PubMed ID: 31166755
    [Abstract] [Full Text] [Related]

  • 5. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C, Hulin C, Latrabe V, Lascaux A, Bordenave L, Hindié E, Marit G.
    Ann Hematol; 2020 Dec 01; 99(12):2869-2880. PubMed ID: 32951093
    [Abstract] [Full Text] [Related]

  • 6. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S, Xue HD, Sun F, Jin ZY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr 01; 31(2):192-9. PubMed ID: 19507599
    [Abstract] [Full Text] [Related]

  • 7. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
    Almeida SD, Santinha J, Oliveira FPM, Ip J, Lisitskaya M, Lourenço J, Uysal A, Matos C, João C, Papanikolaou N.
    Cancer Imaging; 2020 Jan 13; 20(1):6. PubMed ID: 31931880
    [Abstract] [Full Text] [Related]

  • 8. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi JQ, Yan H.
    Acad Radiol; 2018 Jul 13; 25(7):904-914. PubMed ID: 29373210
    [Abstract] [Full Text] [Related]

  • 9. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma.
    Giles SL, Messiou C, Collins DJ, Morgan VA, Simpkin CJ, West S, Davies FE, Morgan GJ, deSouza NM.
    Radiology; 2014 Jun 13; 271(3):785-94. PubMed ID: 24475858
    [Abstract] [Full Text] [Related]

  • 10. [Role of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma].
    Wang PF, Li YC, Xu Y, Wang XM, Guo L, Fu CC.
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb 14; 38(2):129-133. PubMed ID: 28279037
    [Abstract] [Full Text] [Related]

  • 11. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
    Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A, D'Sa S, Dikaios N, Sokolska M, Antonelli M, Ourselin S, Yong K, Taylor SA, Halligan S, Punwani S.
    Eur Radiol; 2017 Dec 14; 27(12):5325-5336. PubMed ID: 28656463
    [Abstract] [Full Text] [Related]

  • 12. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
    Bourillon C, Rahmouni A, Lin C, Belhadj K, Beaussart P, Vignaud A, Zerbib P, Pigneur F, Cuenod CA, Bessalem H, Cavet M, Boutekadjirt A, Haioun C, Luciani A.
    Radiology; 2015 Dec 14; 277(3):773-83. PubMed ID: 26131910
    [Abstract] [Full Text] [Related]

  • 13. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A, Buemi F, Iannessi A, Carriero A, Gallamini A.
    Leuk Lymphoma; 2018 Nov 14; 59(11):2546-2556. PubMed ID: 29431555
    [Abstract] [Full Text] [Related]

  • 14. Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma.
    Wang J, Zhang B, Zhang R, Zhang L, Jiang W, Jiang Y.
    Medicine (Baltimore); 2021 Sep 03; 100(35):e27131. PubMed ID: 34477159
    [Abstract] [Full Text] [Related]

  • 15. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H, Huang W, Ji X, Huang L, Zou D, Hao M, Deng S, Shen Z, Lu X, Wang J, Song Z, Zhang X, Xue H, Xia S.
    AJR Am J Roentgenol; 2022 Feb 03; 218(2):310-319. PubMed ID: 34523949
    [Abstract] [Full Text] [Related]

  • 16. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE.
    Eur Radiol; 2019 Aug 03; 29(8):4503-4513. PubMed ID: 30413957
    [Abstract] [Full Text] [Related]

  • 17. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, Chung HW, Yoon DH.
    Cancer Imaging; 2020 Jan 30; 20(1):14. PubMed ID: 32000858
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of WB-DWI versus 18F-FDG PET/CT for the detection of multiple myeloma.
    Zhang B, Zhang L, Bian B, Lin F, Zhu Z, Wang J.
    Indian J Cancer; 2023 Jan 30; 60(3):303-309. PubMed ID: 37787189
    [Abstract] [Full Text] [Related]

  • 19. Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation.
    Kenkel D, Wurnig MC, Filli L, Ulbrich EJ, Runge VM, Beck T, Boss A.
    Rofo; 2016 Apr 30; 188(4):381-8. PubMed ID: 26815283
    [Abstract] [Full Text] [Related]

  • 20. Whole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?
    Debs P, Fayad LM, Romo CG, Ahlawat S.
    Eur J Radiol; 2023 May 30; 162():110802. PubMed ID: 37001256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.